| Date post: | 19-Jan-2017 |
| Category: |
Health & Medicine |
| Upload: | bioalliance-strategies-llc |
| View: | 666 times |
| Download: | 0 times |
Corporate Development
Jack J. Luchese, MBA Advisor: M&A, Licensing, Capital Raise Office: +1 850.585.4711 Email: [email protected]
General Capabilities
James J. Sarene Managing Director & Founder Phone: +1 919.386.1666 Mobile: +1 704.293.7162 Email: [email protected] Skype ID: jsarene www.bioalliancestrategies.com
WHO WE ARE BioAlliance Strategies, LLC identifies and facilitates strategic relationships utilizing a research driven, integrated corporate and business development and marketing approach. Advisors with transactional, financial, operational and scientific capabilities provide expertise to monetize our client’s assets, services and expand their global reach.
James J. Sarene has over 20 years experience in the Life Sciences working with companies from emerging biotech to large pharmaceuticals. With special expertise in Business Development, M&A and Licensing, Mr. Sarene was Managing Director at Madison Keats, a boutique Charlotte based transactional firm, where he focused on providing clients with strategic partnerships enabling growth opportunities. He also led North American activity as Sr. Director, Business Development for the Indian based clinical research organization CliniRx Research. Mr. Sarene has a B.A. in Psychology from Youngstown State University.
Jack J. Luchese is a seasoned CEO of several companies that executed numerous alliances and fund raising activities, Jack brings a broad prospective to your business.
Mr. Luchese’s Experience Johnson & Johnson Controller Functions and Key Financial management responsibilities Business Development – In and Out-Licensing of technology and products and Product Acquisitions Field Sales Rorer Group (acquired by Rhone-Poulenc) VP, Corporate Development – Mergers & Acquisitions, Divestitures, Product Acquisitions Division CEO – International Pharma/Biologics Business – turnaround, product launches, downsizing, expansion Public Biotech Company – CEO Turnaround Executed key technology deals with Glaxo and Merk Significant, multiple fund raising activities Founded three subsidiaries Acquisitions/Divestitures Medical Device Start-Up Founder Product Launches Fund Raising
STRATEGIC PARTNERSHIPS If you are an emerging growth company you may be considering a strategic partnering strategy to optimize the value of a product opportunity or technology. CONSIDERATIONS • Why a Strategic Partnership? • Selling Your Opportunity • Presenting Your Opportunity • Management Matters • Due Diligence Process • Internal Resources / Project Reviews • Negotiating the Deal • Living the partnership BENEFITS • Brings talent and experience to the opportunity • Brings investor credibility to the opportunity, the management
and the company • Brings direct and/or indirect funding • Reduces execution risk • May bring other tactical and strategic assets to the opportunity • May eliminate the need to immediately raise capital at low
valuations and enable capital raises at a later time, at more favorable valuations
“Be creative and open minded in your thinking and planning. A strategic partner is just that, strategic, not tactical. The right partner for tomorrow may not be one of today’s market leaders or may not be headquartered in the your base country, and the right partner may use your opportunity in a future use that may not be obvious today. This is particularly true if you are dealing with a new, innovative emerging technology.” Jack J. Luchese, MBA
SELLING THE OPPORTUNITY When soliciting a strategic partner, you are seeking the attention of a busy person or team. To ensure you’re taken seriously, these issues must be addressed: • Proper Preparation - A properly prepared presentation, and
due diligence material, speaks well for you and your company • Sales Pitch - Your presentation needs to highlight all the
requirements that are important to the buyer • Shopping Your Opportunity – Many business development
groups that are in charge of finding new opportunities for a company, clearly know what they need and be sure your offering is positioned to fit the partners’ needs
• Presenting Your Opportunity – Who, What and How your pitch is presented matters as you get one chance to make a first impression
• Management Matters – Partners often bet on the management as much as the specific opportunity.
• Due Diligence Process – Your preparedness regarding your due diligence “library” says much about your company
• Internal Resources / Project Reviews – With limited time, it is important for partners to quickly realize your opportunity is worth their time to explore further.
“When soliciting a strategic partner, you are seeking the attention of a busy person or team. This is most likely a team that may receive one new opportunity a day from the outside, so there are usually more opportunities than there are resources (human and financial) to support them.” Jack J. Luchese, MBA
NEGOTIATING THE DEAL Support your efforts with the benefit of a professional who has negotiated numerous deals in the past. Each deal is different and your deal will not be an exception. The deal will include monetary conditions, performance conditions, and a number of other subjective conditions that could very unfavorably impact your ultimate return on any deal you do. One learns to be creative after doing many deals and creativity also comes into play in finalizing all agreements. Complex corporate partnering deals can take months to complete, but the final negotiations are usually concluded over a number of days/weeks. LIVING THE PARTNERSHIP A partnership is a business marriage that includes financial terms which are very important. However, very often it is the non-monetary conditions in the contract that can hurt you the most. Furthermore, they may represent issues you have little control over without protective language. Again, all deals are different but the support of a professional will enable you to better live through and prosper with the partnership over time.
“Very rarely are there ‘plain vanilla’ deals especially with high value products and technologies. Again, the support from a professional is always a good idea at the negotiating table.” Jack J. Luchese, MBA
Experience Professionals
Managing Director & Founder: James J. Sarene has over 18 years experience in the Life Sciences working with companies from emerging biotech to large pharmaceuticals. With special expertise in Business Development, M&A and Licensing, Mr. Sarene was Managing Director at Madison Keats, a boutique Charlotte based transactional firm, where he focused on providing clients with strategic partnerships enabling growth opportunities. More
Managing Director: Jared Byer, MBA manages business development and marketing program strategies and execution. Jared is a communications and business development professional with over 15 years of experience in the clinical research industry. Earlier experience includes positions as a technical writer for a leading environmental testing company and as a writer for The Kansas City Times. More
Managing Director: Munaf Ali, Ph.D. obtained his PhD at Imperial College, University of London in 1987 in the field of Molecular Virology. Dr. Ali has over 20 years of experience in regulatory affairs and CNS drug development. From 1996 to 1999, Dr. Ali was a principal scientific reviewer at MHRA, including membership in the European Biotech Working Party and CHMP representative for the UK at the European Medicines Agency (EMA). More
Advisor: Jack J. Luchese, MBA. Has 30+ years experience with both large global co.’s and small start-up emerging companies where he served 20+ years at general manager/Board-level including CEO & Chairman. Mr. Luchese has a strong financial background and experience in commercial deal making, operating and management along with public operating companies as well as public financings. More
Experience Professionals
Managing Director & Founder: James J. Sarene has over 18 years experience in the Life Sciences working with companies from emerging biotech to large pharmaceuticals. With special expertise in Business Development, M&A and Licensing, Mr. Sarene was Managing Director at Madison Keats, a boutique Charlotte based transactional firm, where he focused on providing clients with strategic partnerships enabling growth opportunities. More
Managing Director: Jared Byer, MBA manages business development and marketing program strategies and execution. Jared is a communications and business development professional with over 15 years of experience in the clinical research industry. Earlier experience includes positions as a technical writer for a leading environmental testing company and as a writer for The Kansas City Times. More
Managing Director: Munaf Ali, Ph.D. obtained his PhD at Imperial College, University of London in 1987 in the field of Molecular Virology. Dr. Ali has over 20 years of experience in regulatory affairs and CNS drug development. From 1996 to 1999, Dr. Ali was a principal scientific reviewer at MHRA, including membership in the European Biotech Working Party and CHMP representative for the UK at the European Medicines Agency (EMA). More
Advisor: Jack J. Luchese, MBA. Has 30+ years experience with both large global co.’s and small start-up emerging companies where he served 20+ years at general manager/Board-level including CEO & Chairman. Mr. Luchese has a strong financial background and experience in commercial deal making, operating and management along with public operating companies as well as public financings. More
Advisors: Operational, Scientific and Technology
Patrick R. Ayd, BSN, MBA – Advisor, Clinical Sites
Romano Robusto, LLB, B.CL., B.Sc. – Advisor, Medical Devices
Richard M. Hahn Chief Creative Officer Branding / Web Design
Karen Watson-Robin – Advisor, Strategic Sales
Patrick D. Mize, Ph.D. – Advisor, Product Development / Regulatory Services
David Dworaczyk, Ph.D. – Advisor, Scientific
Imen Jelassi, PharmaD, MSc – Advisor, Strategic Sales, Marketing
Jamie McMahon – Manager, Marketing Operations
Contact Us
Office: +1 919.386.1666Mobile: +1 704.293.7162Email: [email protected]: www.bioalliancestrategies.com
James J. SareneManaging Director& Founder
